- Investing Ideas
- /
- U.S. Undervalued Stocks Based On Cash Flows
U.S. Undervalued Stocks Based On Cash Flows
Results
171
0 new
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
171 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
TLRY | US$1.93 | 9.7% | 16.3% | US$1.6b | US$2.37 | PS2.1x | E78.9% | n/a | Pharmaceuticals & Biotech | ||
TAL | US$10.00 | -6.5% | 66.7% | US$6.1b | US$16.08 | PS4.1x | E42.1% | 0% | Consumer Services | ||
HGV | US$44.17 | 14.3% | -7.2% | US$4.4b | US$55.29 | PE19.4x | E32.4% | n/a | Consumer Services | ||
VSTA | US$3.01 | 0.3% | -11.4% | US$231.8m | US$4.12 | PB0.3x | E83.2% | n/a | Consumer Services | ||
UMBF | US$97.08 | 16.0% | 44.4% | US$4.5b | US$97.17 | PB1.5x | E21.8% | 1.6% | Banks | ||
NTNX | US$50.38 | -15.2% | 74.2% | US$12.8b | US$74.54 | PS5.9x | E82.8% | n/a | Software | ||
MAX | US$14.29 | 11.8% | 46.4% | US$898.8m | US$25.33 | PS1.8x | E88.1% | n/a | Media | ||
ALNY | US$249.83 | -1.9% | 19.9% | US$32.4b | US$254.65 | PS15.8x | E63.5% | n/a | Pharmaceuticals & Biotech | ||
NE | US$48.26 | 11.2% | -7.2% | US$6.8b | US$58.55 | PE14.7x | E29.8% | 4.1% | Energy | ||
LGIH | US$107.23 | 24.9% | -22.9% | US$2.4b | US$109.00 | PE13.3x | E22.0% | n/a | Consumer Durables | ||
NAPA | US$7.48 | 13.2% | -40.3% | US$1.1b | US$9.67 | PE17.6x | E24.9% | n/a | Food, Beverage & Tobacco | ||
APP | US$86.53 | 2.1% | 205.7% | US$28.9b | US$93.93 | PE47.9x | E24.8% | n/a | Software | ||
MVBF | US$22.44 | 18.9% | -3.8% | US$273.8m | US$23.25 | PB1x | E23.1% | 3.0% | Banks | ||
BZ | US$17.21 | -6.8% | 14.6% | US$7.9b | US$26.05 | PE42.5x | E23.4% | n/a | Media | ||
GDYN | US$11.81 | 14.1% | 6.1% | US$864.7m | US$14.64 | PE400.4x | E57.1% | n/a | Software | ||
VCTR | US$53.04 | 12.1% | 54.4% | US$3.4b | US$52.00 | PE15.7x | E34.0% | 2.8% | Diversified Financials | ||
SE | US$71.22 | -3.2% | 15.9% | US$41.3b | US$78.88 | PE1049.2x | E41.8% | n/a | Media | ||
HNVR | US$17.07 | 5.5% | -4.4% | US$122.1m | US$18.50 | PB0.7x | E20.9% | 2.3% | Banks | ||
HBIO | US$3.54 | 27.3% | -31.9% | US$144.2m | US$7.00 | PS1.4x | E106.7% | n/a | Pharmaceuticals & Biotech | ||
VAC | US$90.46 | 11.1% | -32.1% | US$3.1b | US$108.75 | PE14.9x | E24.1% | 3.4% | Consumer Services | ||
DQ | US$17.20 | 11.1% | -55.0% | US$1.0b | US$23.41 | PE6.8x | E38.5% | n/a | Semiconductors | ||
WEX | US$189.84 | 6.6% | -2.9% | US$7.8b | US$237.74 | PE30.1x | E27.6% | n/a | Diversified Financials | ||
HTLF | US$52.10 | 16.6% | 64.8% | US$2.1b | US$52.00 | PB1.2x | E44.5% | 2.3% | Banks | ||
KNSA | US$22.35 | 10.5% | 40.4% | US$1.5b | US$30.67 | PE183.7x | E44.1% | n/a | Pharmaceuticals & Biotech |